Skip to main content
. 2021 Jan 21;6:27. doi: 10.1038/s41392-020-00388-0

Fig. 3.

Fig. 3

Expression of a dominant-negative MAML1 reduced the growth of MEC xenografts. GFP-expressing and dnMAML1-expressing H3118 cells (1 × 106 cells/mouse) were subcutaneously injected to the right flanks of 8–12-week-old immune-deficient NOD.SCID mice (n = 7 each group). Mice were euthanized after a 16-day xenograft study. ac The tumor volumes were measured daily after tumor cell injection (a), and tumor size (b) and tumor weight (c) were presented at the endpoint. d Representative images of Ki-67 staining of H3118-dnMAML1 and control H3118-GFP xenografts (left bar = 100 μm, right bar = 25 μm) were shown. ImageJ was used to analyze Ki-67-positive cells in IHC staining results. Sections of individual tumors (n = 3) in each group were analyzed. The data were presented as the percentage (%) of Ki-67 positive nuclei to the total nuclei. e The expression levels of GFP, dnMAML1, and HES1 in xenograft tumors were analyzed by western blotting (**p < 0.01; ***p < 0.001)